Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a +1.8% change compared to its last close.
Novo Nordisk stock plunges 42% so far in 2025 as GLP-1 competition, price cuts, guidance trims and restructuring plans cloud ...
Eli Lilly and Co shared updated results of Inluriyo (imlunestrant) from a Phase 3 study in previously treated breast cancer patients.
Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.
Investing.com -- Moody’s Ratings has affirmed Eli Lilly and Company’s Aa3 senior unsecured notes ratings and long-term issuer rating while revising the outlook to positive from stable, the rating ...
Investor's Business Daily on MSN
Dow Jones, Russell 2000 hit highs, buoyed by Fed; Oracle, Broadcom weigh on techs: Weekly review
The Dow Jones and Russell 2000 hit record highs this past week, buoyed by a Fed rate cut and dovish Fed Chief Powell.
The pharmaceutical giant Eli Lilly has once again raised the bar in the highly competitive obesity treatment market. New clinical trial data for its experime ...
Major stock indexes ended mixed Thursday, with the Dow Jones Industrial Average and S&P 500 closing at record highs but the ...
Eli Lilly's shares may appear expensive at first glance, but a closer look reveals a different story. The company's outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback